arrow
T

Tom Venken

royal marsden nhs foundation trust
H指数:13
被引数:553

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A pipeline of machine learning-driven multi-modal data fusion methods for prognostic risk analysis in bevacizumab-treated metastatic colorectal cancer

一种基于机器学习的多模态数据融合方法流程,用于贝伐珠单抗治疗转移性结直肠癌的预后风险分析

2026-04-010
OAAI
Interrogating the immune landscape of microsatellite stable RAS-mutated colon cancer

探究微卫星稳定型RAS突变结肠癌的免疫景观

2026-02-240
OAAI
Progression-free survival for unresectable non-metastatic locally advanced pancreatic cancer after surgical microwave ablation plus durvalumab and tremelimumab: phase-2 non-randomized prospective clinical trial

不可切除的非转移性局部晚期胰腺癌在行手术治疗联合微波消融、durvalumab和tremelimumab后的无进展生存期:二期非随机前瞻性临床研究

2025-11-180
OAAI
Decoding tumor heterogeneity: A spatially informed pan-cancer analysis of the tumor microenvironment

解码肿瘤异质性:一项关于肿瘤微环境的基于空间信息的泛癌分析

2025-10-140
OAAI
Single-Nucleus RNA-Sequencing Identifies a Differential Profibrotic Response in Parietal Epithelial Cells in Primary Versus Maladaptive Focal Segmental Glomerulosclerosis

单核RNA测序识别原发性与适应性不良型局灶节段性肾小球硬化中壁层上皮细胞的差异促纤维化反应

2025-06-180
OAAI
Secreted Apoe rewires melanoma cell state vulnerability to ferroptosis

分泌的Apoe重新连接黑色素瘤细胞状态对铁死亡的脆弱性

2024-10-181
OAAI
PARP inhibitor predictive value of the Leuven HRD test compared with Myriad MyChoice CDx PLUS HRD on 468 ovarian cancer patients from the PAOLA-1/ENGOT-ov25 trial
2023-07-0111
PRE
Multiomics and spatial mapping characterizes human CD8+T cell states in cancer
2023-04-1238
OA
Analysis of cell free DNA to predict outcome to Bevacizumab combination therapy in metastatic colorectal cancer patients
2023-04-040
OA